Yuji Aoki. “Comparison of Diuretic Effects Between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics”. Diabetes Research 2, no. 2 (October 28, 2016): 45–49. Accessed July 29, 2026. https://openventio.us/index.php/DR/article/view/1621.